SCHEMBL2389787

SCHEMBL2389787

O=C(c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)N1CCC(c2cccnc2)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.61
CYP3A4 P08684 1/20 0.55
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
ATM Q13315 1/20 0.52
SPR P35270 1/20 0.52
SLC6A7 Q99884 1/20 0.51
RORC P51449 3/20 0.49
HSD11B1 P28845 2/20 0.48
KCNH2 Q12809 1/20 0.48
PROKR1 Q8TCW9 2/20 0.48
GAA P10253 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
KMT2A Q03164 1/20 0.47
HTR2B P41595 1/20 0.47
PDE2A O00408 1/20 0.47
PDE3A Q14432 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2390000 0.93 NAMPT (0.61) NAMPTCYP3A4NPC1RAB9AATM
SCHEMBL2391018 0.91 NAMPT (0.57) NAMPTCYP3A4NPC1RAB9AATM
SCHEMBL2390969 0.91 NAMPT (0.59) NAMPTCYP3A4NPC1RAB9AATM
SCHEMBL2391187 0.91 NAMPT (0.58) NAMPTCYP3A4NPC1RAB9AATM
SCHEMBL2390915 0.90 NAMPT (0.64) NAMPTNPC1RAB9AATMSPR
SCHEMBL2387812 0.89 NAMPT (0.62) NAMPTCYP3A4NPC1RAB9AATM
SCHEMBL12255559 0.89 NAMPT (0.56) NAMPTCYP3A4NPC1RAB9AATM
SCHEMBL2385513 0.88 NAMPT (0.76) NAMPTCYP3A4NPC1RAB9AATM
SCHEMBL2390864 0.88 NAMPT (0.64) NAMPTNPC1RAB9AATMSPR
SCHEMBL2388608 0.88 NAMPT (0.64) NAMPTNPC1RAB9AATMSPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367679-B2 Biaryl carboxamides MERCK SHARP & DOHME CORP. (US) 2013-02-05 US claimed
US-20110230498-A1 BIARYL CARBOXAMIDES MERCK SHARP & DOHME CORP. 2011-09-22 US claimed
EP-2375904-B1 BIARYL CARBOXAMIDES MERCK SHARP & DOHME (US) 2014-05-28 EP disclosed
US-8367679-B2 Biaryl carboxamides MERCK SHARP & DOHME CORP. (US) 2013-02-05 US disclosed
EP-2375904-A1 BIARYL CARBOXAMIDES Merck Sharp & Dohme Corp. (US) 2011-10-19 EP disclosed
US-20110230498-A1 BIARYL CARBOXAMIDES MERCK SHARP & DOHME CORP. 2011-09-22 US disclosed
WO-2010077624-A1 BIARYL CARBOXAMIDES MERCK SHARP & DOHME CORP. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230498-A1 BIARYL CARBOXAMIDES PAFAH1B3, PAFAH1B2, FAAH2 NAMPT 2170/4885CYP3A4 2200/4885NPC1 561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.